BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Vimpat (Lacosamide) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Vimpat (Lacosamide)\, from ClinicalTrials
 .gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07412132-6316@assetmemo.bio
DTSTAMP:20261121T004049Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:Vimpat (Lacosamide): Phase 3 readout est. (NCT07412132)
DESCRIPTION:Vimpat (Lacosamide)\, phase 3.\nStudy: Evaluation of the Effica
 cy\, Safety\, and Tolerability of Lacosamide in Major Depressive Episodes 
 of Bipolar Disorder Types I and II.\nEstimated primary completion: January
  2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout dat
 e\, and it can move.\nDrug page: https://assetmemo.bio/drug/lacosamide#upc
 oming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0741213
 2
URL:https://assetmemo.bio/drug/lacosamide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05603702-6316@assetmemo.bio
DTSTAMP:20261121T004049Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:Vimpat (Lacosamide): Phase 1 readout est. (NCT05603702)
DESCRIPTION:Vimpat (Lacosamide)\, phase 1.\nStudy: STTEPP: Safety\, Tolerab
 ility and Dose Limiting Toxicity of Lacosamide in Patients With Painful Ch
 ronic Pancreatitis\nEstimated primary completion: 31 March 2027. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/lacosamide#upcoming-events\nRe
 gistry record: https://clinicaltrials.gov/study/NCT05603702
URL:https://assetmemo.bio/drug/lacosamide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06866691-6316@assetmemo.bio
DTSTAMP:20261121T004049Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:Vimpat (Lacosamide): Phase 4 readout est. (NCT06866691)
DESCRIPTION:Vimpat (Lacosamide)\, phase 4.\nStudy: Seizure Prevention in Tr
 aumatic Brain Injury With Levetiracetam and Lacosamide\nEstimated primary 
 completion: April 2027. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/lacosamide#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT06866691
URL:https://assetmemo.bio/drug/lacosamide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
